- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NPPA panel fixes price of Intas Pharma oncology drug, Details
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of an oncology drug combination pack of Trastuzumab lyophilized powder for concentrate for solution for infusion vial 375 mg and Bacteriostatic Water for Injection USP 20 ml Vial, manufactured and marketed by lntas Pharmaceuticals, at Rs.17500.00 per vial excluding GST.
The recommendation was made by the Multidisciplinary Committee of Experts at its 33rd meeting held on 21.06.2021. The issue of the retail price fixation of the combipack of (a) Trastuzumab lyophilized powder for concentrate for solution for infusion vial 375 mg and (b) Bacteriostatic Water for Injection USP 20 ml Vial for lntas Pharmaceuticals was addressed during the meeting.
Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. Trastuzumab binds to HER2 and suppresses cancer cells growth, proliferation, and survival directly and indirectly.
In the latest Multidisciplinary Committee meeting, the committee noted that the retail price claimed by lntas Pharmaceuticals for Combipack of (a) Trastuzumab lyophilized powder for concentrate for solution for infusion vial 375 mg and (b) Bacteriostatic Water for Injection USP 20 ml Vial at Rs. 17500 per vial.
After detailed deliberation, the committee recommended the retail price of each Combipack of (a) Trastuzumab lyophilized powder for concentrate for solution for infusion vial 375 mg and (b) Bacteriostatic Water for Injection USP 20 ml Vial for M/s lntas Pharmaceuticals Ltd. (manufacturer and marketer) at Rs. 17500 per vial excluding GST as detailed below:
a. Worked out Price
Retail price provided for Trastuzumab 150 mg vial at Rs: 15526.97 per vial excluding GST vide SO. 2334(E) dated 15.06.2021.
Derived retail price as per recommendation of Pronab Sen committee: P(s) = P*.[1+a.{(s-s*)/s*}]
Where : P(s) = Price ceiling of the strength s,
P* = price ceiling for reference strength s* s = strength in terms of API content
s* = reference strength
a= 0.8 for pack/ capsule and 0.7 for injectibles.
Derived Retail price for Trastuzumab 375 mg/50 ml Pack= 15526.97[1+0.70{375- 150)/150}] = Rs. 31830.29 per pack
b. Retail price claimed by lntas Pharmaceuticals Ltd Rs. 17500.00 per vial
c. Recommended retail price =Rs. 17500.00 per vial excluding GST